Evidence map›Paper›PMID 29952797›Full record

ReviewClinical obstetrics and gynecology2018

Management of the Perimenopause.

Lara Delamater, Nanette Santoro

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Clinical obstetrics and gynecology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06398236 nacompletednot on this mapstarted 2023, after this paper: background citation

Multicentre, Exploratory, Prospective, Open-labelled, Non-controlled Study to Evaluate the Effect of SE5-OH Tablets on Healthy Women With Menopausal Symptoms

TypeinterventionalSponsorNutrition & Sante IberiaRan2023 to 2024Enrolled170ConditionsMenopauseArmsSE5-OH tablets
NCT06798584 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Rough Journey to Menopause: How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?

TypeinterventionalSponsorPurdue UniversityRan2025 to 2025Enrolled240ConditionsIron Deficiency Anemia Treatment, Iron Deficiency, Iron Deficiency (Without Anemia)ArmsFeoSol Original Iron Supplement Tablets, 21st Century Gelatin Capsules
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Australian Women's Knowledge of Perimenopause and Menopause.Journal of transcultural nursing : official journal of the Transcultural Nursing Society · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. The special extract ERr 731Frontiers in pharmacology · 2026
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lara DelamaterDepartment of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado.
Nanette Santoro

Funding

Women's Health Across the Nation-New Jersey SiteU01AG012535 · NIA · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DERBY, CAROL A. · 1994 to 2019
$9.2M
NIA NIH HHS U01 AG012535
6 · The paper itself

Abstract

Perimenopause, or the menopausal transition, represents a period of time during which newly arising symptoms can present complex management decisions for providers. Many women present to care with complaints of hot flashes, vaginal and sexual changes, altered mood and sleep, and changing bleeding patterns. The effect of these symptoms on quality of life, even before a woman enters menopause, can be significant. The appropriate evaluation and evidence-based management of women in this transition is reviewed in this article. Two case vignettes are used to highlight certain evaluation and treatment challenges.

Indexed as

AffectAndrogensAnti-Mullerian HormoneBiomarkersEvidence-Based PracticeFemaleFollicle Stimulating HormoneHot FlashesHumansMenstruation DisturbancesPerimenopauseSexual Dysfunction, PhysiologicalSleep Initiation and Maintenance DisordersAndrogensAnti-Mullerian HormoneBiomarkersFollicle Stimulating Hormone

Identifiers

PMID29952797
PMCPMC6082400

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.